Bigul

Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus applies to the DCGI for EUA to launch ZyCoV-D, the world's first Plasmid DNA vaccine for COVID-19
01-07-2021

COVID-19: Zydus Cadila vaccine likely to be available for 12-18 years age group by Aug

The Ahmedabad-based company's ZyCoV-D is a DNA plasmid vaccine, which uses a portion of the genetic code -- DNA or RNA -- in the virus to stimulate an immune response.
27-06-2021

Zydus Cadila gets USFDA approval for generic cancer drug

The Ahmedabad-based drug maker has received approval from the US Food and Drug Administration (USFDA) for the injection in the strengths of 100mg/vial, 500 mg/vial, and 1000 mg/vial, single-dose vials, Zydus Cadila said in a statement.
25-06-2021
Bigul

CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Cadila receives tentative approval from USFDA for Pemetrexed for Injection
25-06-2021

Zydus Cadila gets tentative USFDA nod to market generic sclerosis treatment drug

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market the product in the strength of .25 mg, Zydus Cadila said in a statement
24-06-2021
Bigul

Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg
24-06-2021
Bigul

Cadila Healthcare Ltd - 532321 - Closure of Trading Window

Intimation of Trading Window Closure
22-06-2021
Bigul

Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus and Bayer announce continuity of their successful Joint Venture
21-06-2021
Bigul

CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Updates on Joint Venture

Extention of the tenure of the joint venture agreement ('JVA') with Bayer (South East Asia) PTE Limited, one of the companies of the Bayer Group, for a period of three years.
21-06-2021

Zydus Cadila likely to seek EUA for its ZyCoV-D vaccine in 7-8 days

It will be the second indigenous Covid-19 vaccine to apply for such authorisation. It will also be the world's first DNA vaccine against coronavirus
18-06-2021
Next Page
Close

Let's Open Free Demat Account